Christine Holloway
Adult Health · New York, NYNPI 1508385840
Payments from drug & device makers
Across 561 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Nevro Corp.$1K
- Collegium Pharmaceutical, Inc.$1K
- Biohaven Pharmaceuticals, Inc.$981
- Amgen$931
- plus $4K from 31 others
What the payments were for
- Consulting fees$8007%
- Food & beverage$11,25393%
- Education$480%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 90 | $2,080 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 165 | $1,868 |
| Nevro Corp. | 23 | $1,249 |
| Collegium Pharmaceutical, Inc. | 83 | $1,176 |
| Biohaven Pharmaceuticals, Inc. | 5 | $981 |
| Amgen(2 entities) | 45 | $931 |
| Azurity Pharmaceuticals, Inc. | 21 | $505 |
| Medtronic | 8 | $501 |
| Boston Scientific | 8 | $296 |
| Globus Medical | 2 | $286 |
| Scilex Pharmaceuticals Inc. | 13 | $244 |
| Redhill Biopharma Inc. | 18 | $227 |
| Hikma Pharmaceuticals USA | 11 | $201 |
| Forte Bio-pharma LLC | 9 | $188 |
| Axsome Therapeutics, Inc. | 3 | $187 |
| GRT US Holding, Inc. | 2 | $130 |
| Pfizer | 6 | $123 |
| Abbott | 2 | $95 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $95 |
| Eisai Inc. | 6 | $88 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
| Merck | 6 | $79 |
| Valinor Pharma, LLC | 3 | $68 |
| Biodelivery Sciences International, Inc. | 4 | $59 |
| Ipsen Biopharmaceuticals, Inc | 3 | $49 |
| Vertex | 2 | $48 |
| Saluda Medical Americas, Inc. | 1 | $34 |
| Virtus Pharmaceuticals LLC | 2 | $32 |
| Novartis | 2 | $31 |
| Almatica Pharma LLC | 2 | $27 |
| Lundbeck LLC | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $23 |
| USWM, LLC | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,101 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 288 | $91,987 |
| RelistorMethylnaltrexone Bromide | 30 | $69,904 |
| Xtampza ErOxycodone Myristate | 81 | $65,835 |
| OxycontinOxycodone Hcl | 65 | $35,106 |
| Nurtec OdtRimegepant Sulfate | 16 | $30,823 |
| Naproxen-Esomeprazole MagNaproxen/Esomeprazole Mag | 24 | $28,110 |
| ZtlidoLidocaine | 41 | $27,877 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 123 | $24,169 |
| BelbucaBuprenorphine Hcl | 24 | $22,850 |
| UbrelvyUbrogepant | 21 | $21,540 |
| LinzessLinaclotide | 27 | $18,726 |
| Diclofenac Epolamine | 29 | $17,576 |
| Lidocaine | 129 | $11,633 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 481 | $11,319 |
| MovantikNaloxegol Oxalate | 22 | $8,892 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $1,176 | $88,685105 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,868 | $69,90430 claims |
| AbbVieUbrelvy, Linzess | $2,080 | $40,26648 claims |
| PfizerNurtec Odt | $123 | $30,82316 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $244 | $27,87741 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate, Buprenorphine Hcl | $201 | $25,660165 claims |
| Redhill Biopharma Inc.Movantik | $227 | $8,89222 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $19 | $8,70814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in New York
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Jenna WenzelNew York$22K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.